TerminatedPhase 2NCT02518672

Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
SCF Pharma
Principal Investigator
André M Cantin, M.D.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Intervention
MAG-DHA(dietary_supplement)
Enrollment
11 enrolled
Eligibility
18 years · All sexes
Timeline
20152016

Study locations (1)

Collaborators

Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Solutex GC S.L.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02518672 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials